Pinealon — Safety, Research, Risks & Legal Status

Not medical advice. Pinealon is discussed here for informational and harm-reduction purposes only. We do not endorse use, and any dosing context is informational, not a protocol.

Also known as	epithalamine, epitalon, pineal peptide
Category	Peptide
telomere	Repetitive DNA sequence protecting chromosome ends; shortens with cell division, limiting replicative lifespan
telomerase	Enzyme adding telomeric DNA; active in germ cells and cancer; mostly silent in somatic cells
pineal gland	Small endocrine gland in brain; produces melatonin; involved in circadian rhythm regulation
US legal status	Research chemical; not FDA-approved; sold as research chemical in US; prescribed in Russia for age-related conditions but no US regulatory approval

What is Pinealon?

Tetrapeptide (Ala-Glu-Asp-Gly) derived from bovine pineal extract; marketed to support circadian rhythm, sleep, and pineal function; preclinical work suggests telomerase activation but human data is very limited. Pinealon is promoted as an anti-aging and longevity agent based on animal studies in ex-Soviet countries.

How it works

Pinealon is a tetrapeptide believed to enhance telomerase activity in cells, promoting telomere lengthening and potentially extending cellular lifespan. It may also influence melatonin production and circadian clock genes in the pineal gland, supporting sleep-wake rhythms and antioxidant defense. Exact cellular targets and signaling pathways are not fully elucidated.

Background & history

Pinealon (epithalamin, epitalon) research originated in Russia and post-Soviet countries in the 1990s-2000s. Vladimir Khavinson's laboratory published extensively on telomerase activation and lifespan extension in rodents and frogs. Western scientific community remains skeptical due to limited peer-review, small human trials, and publication bias. Commercial interest grew despite minimal English-language validation.

What the research says

Mostly preclinical and animal studies showing telomerase upregulation and lifespan extension in mice; very few published human trials; strong marketing claims exceed available evidence; mostly studied in ex-Soviet countries with limited peer review. Anecdotal human reports exist but lack robust clinical validation; extrapolation from mice to humans is unwarranted.

Reported effects

Preclinical studies suggest potential telomerase activation
Animal research shows possible lifespan extension and sleep support
Marketed to promote melatonin production and circadian rhythm regulation
Some studies in elderly rodents show improved cognitive performance
Reported in some clinical studies (mostly Russian) to improve sleep quality and subjective well-being

Dosing & administration (informational)

Animal studies used peptide doses of 1-10 mg/kg intraperitoneally or orally. Russian clinical trials cited 10 mg injected daily or several times weekly for 10-30 days, sometimes repeated. No Western randomized controlled trials; pharmacokinetics in humans are unknown. Suppliers vary widely in dosing recommendations.

This is general research/context information, not medical advice or a recommended protocol.

Safety & side effects

Extremely limited human safety data; no long-term studies or large trials
Preclinical data shows no obvious toxicity but provides limited reassurance for humans
Injection route carries standard contamination and sterility risks if not GMP
Theoretical concern: uncontrolled telomerase activation could favor tumor growth, though not demonstrated in animals or humans
Pregnancy/nursing: avoid (no data at all)
Immunosuppressed individuals: effects on immune regulation unknown

Drug & supplement interactions

Potential interaction with melatonin supplements (combined circadian modulation untested)
Benzodiazepines or sleep drugs: combined CNS effects unknown
Immunosuppressants: telomerase activation and immune cell function interaction unclear
Telomerase inhibitors (some cancer drugs): direct antagonism possible

Who should avoid it

History of cancer or active cancer (telomerase activation could theoretically promote tumor cells)
Pregnancy and nursing (no safety data; developmental risks unknown)
Severe immunocompromise (immune cell telomerase involvement untested in vulnerable populations)
Sleep apnea or severe circadian disorders (mechanism in pathology unclear; could worsen)
Concurrent enrollment in telomerase-targeting drug trials

How it is commonly combined

Pinealon is sometimes combined with other anti-aging peptides (SS-31, BPC-157), melatonin, or antioxidants (NAC, alpha-lipoic acid) in informal longevity protocols, but no studies validate safety or efficacy of combinations.

Legal & regulatory. Research chemical; not FDA-approved; sold as research chemical in US; prescribed in Russia for age-related conditions but no US regulatory approval

Quality & harm reduction

T
h
i
r
d
-
p
a
r
t
y
C
O
A
a
b
s
o
l
u
t
e
l
y
r
e
q
u
i
r
e
d
;
v
e
r
i
f
y
p
u
r
i
t
y
(
H
P
L
C
9
5
%
+
a
c
c
e
p
t
a
b
l
e
g
i
v
e
n
s
y
n
t
h
e
s
i
s
v
a
r
i
a
b
i
l
i
t
y
)
.
L
C
-
M
S
o
r
a
m
i
n
o
a
c
i
d
s
e
q
u
e
n
c
i
n
g
t
o
c
o
n
f
i
r
m
t
e
t
r
a
p
e
p
t
i
d
e
i
d
e
n
t
i
t
y
.
E
n
d
o
t
o
x
i
n
t
e
s
t
i
n
g
l
e
s
s
t
h
a
n
0
.
2
5
I
U
/
k
g
;
s
t
e
r
i
l
i
t
y
t
e
s
t
i
n
g
i
f
a
v
a
i
l
a
b
l
e
.
F
r
e
e
z
e
s
t
a
b
l
e
(
-
2
0
°
C
)
o
r
r
e
f
r
i
g
e
r
a
t
e
2
-
8
°
C
;
s
i
n
g
l
e
-
u
s
e
v
i
a
l
s
o
n
l
y
;
c
o
l
d
c
h
a
i
n
m
a
i
n
t
a
i
n
e
d
.

Safer, legal alternative we recommend

Quality sleep, sunlight exposure, and melatonin supplement. Sleep consistency, morning light, and over-the-counter melatonin all support circadian rhythm and are proven safe without injection or telomerase speculation.

See our recommended pick

Lab testing & harm-reduction tools

If you are going to research a compound, verifying identity and purity is the single most protective step. Independent analytical testing and sterile-handling supplies reduce risk.

Compare testing options

Frequently asked questions

Does pinealon extend human lifespan?

Unknown. Mouse data is suggestive but translating animal lifespan studies to humans is speculative. No human long-term data exists.

Will it improve my sleep?

Anecdotal reports suggest possible sleep benefit, but no rigorous human trials confirm it. Melatonin and sleep hygiene are proven alternatives.

Is it safe?

Unknown. Preclinical data shows no red flags, but human long-term safety is not established. Telomerase activation theory raises theoretical (not proven) cancer concern.

Why is it available if there is no human data?

Pinealon is more established in ex-Soviet countries; Western regulatory agencies have not approved it due to insufficient evidence. It is sold as research chemical in US.

Could pinealon activate cancer cell telomerase?

Theoretically possible but not demonstrated in animal or human studies. Cancer cells are already telomerase-active; effect of pinealon on tumor growth is unknown.

References & further reading

Telomerase and aging: Nature Reviews and Aging journals
Pinealon and epithalamin preclinical studies: mostly Russian and Eastern European publications; limited English peer review
Pineal gland and circadian biology: neuroscience and endocrinology literature
Telomerase activation and cancer risk: oncology and cell biology journals
Sleep and melatonin regulation: sleep medicine and circadian neuroscience texts